Buldhana, India

Snehal Rameshwar Palwe

This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wockhardt Limited. Active years: 2019-2020.

USPTO Granted Patents = 2 

% Patents Active = 50.0


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Buldhana, IN (2019)
  • Buldana, IN (2020)

Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Snehal Rameshwar Palwe: Innovator in Pharmaceutical Compositions

Introduction

Snehal Rameshwar Palwe is a notable inventor based in Buldhana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. With a total of 2 patents, his work is recognized for its potential impact on healthcare.

Latest Patents

Palwe's latest patents include innovative pharmaceutical compositions that comprise antibacterial agents. One of his patents focuses on compositions containing aztreonam or a pharmaceutically acceptable derivative, along with a compound of Formula (I) or its stereoisomers. Another patent details a pharmaceutical composition that includes a carbapenem antibacterial agent, such as imipenem, meropenem, ertapenem, or doripenem, combined with a compound of Formula (I) or its derivatives.

Career Highlights

Palwe is currently associated with Wockhardt Limited, a prominent player in the pharmaceutical industry. His work at Wockhardt has allowed him to explore and develop groundbreaking solutions in the field of medicine.

Collaborations

Some of his notable coworkers include Mahesh Vithalbhai Patel and Sachin Subhash Bhagwat. Their collaboration has contributed to the advancement of innovative pharmaceutical solutions.

Conclusion

Snehal Rameshwar Palwe's contributions to pharmaceutical compositions highlight his role as an innovator in the field. His patents reflect a commitment to improving healthcare through effective antibacterial agents.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…